-
Something wrong with this record ?
Is severe pulmonary hypertension a contraindication for orthotopic heart transplantation? Not any more
J. Kettner, Z. Dorazilová, I. Netuka, J. Malý, H. Al-Hiti, V. Melenovský, I. Skalský, H. Říha, I. Málek, J. Kautzner, J. Pirk
Language English Country Czech Republic
Document type Research Support, Non-U.S. Gov't
Grant support
NS10497
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Combined Modality Therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Hypertension, Pulmonary etiology physiopathology prevention & control MeSH
- Heart-Assist Devices MeSH
- Heart Failure surgery complications physiopathology MeSH
- Heart Transplantation contraindications MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
Pulmonary hypertension (PH) unresponsive to pharmacological intervention is considered a contraindication for orthotopic heart transplantation (OHTX) due to risk of postoperative right-heart failure. In this prospective study, we describe our experience with a treatment strategy of improving severe PH in heart transplant candidates by means of ventricular assist device (VAD) implantation and subsequent OHTX. In 11 heart transplantation candidates with severe PH unresponsive to pharmacological intervention we implanted VAD with the aim of achieving PH to values acceptable for OHTX. In all patients we observed significant drop in pulmonary pressures, PVR and TPG (p<0.001 for all) 3 months after VAD implantation to values sufficient to allow OHTX. Seven patients underwent transplantation (mean duration of support 216 days) while none of patients suffered right-side heart failure in postoperative period. Two patients died after transplantation and five patients are living in very good condition with a mean duration of 286 days after OHTX. In our opinion, severe PH is not a contraindication for orthotopic heart transplantation any more.
Department of Cardiology Institute for Clinical and Experimental Medicine IKEM Prague
Department of Cardiovascular Surgery Institute for Clinical and Experimental Medicine IKEM Prague
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12006465
- 003
- CZ-PrNML
- 005
- 20141009171827.0
- 007
- ta
- 008
- 120301s2011 xr d f 000 0eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932158 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kettner, Jiří, $d 1956- $7 jo2003193175 $u Department of Cardiology, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 245 10
- $a Is severe pulmonary hypertension a contraindication for orthotopic heart transplantation? Not any more / $c J. Kettner, Z. Dorazilová, I. Netuka, J. Malý, H. Al-Hiti, V. Melenovský, I. Skalský, H. Říha, I. Málek, J. Kautzner, J. Pirk
- 504 __
- $a Literatura $b 16
- 520 9_
- $a Pulmonary hypertension (PH) unresponsive to pharmacological intervention is considered a contraindication for orthotopic heart transplantation (OHTX) due to risk of postoperative right-heart failure. In this prospective study, we describe our experience with a treatment strategy of improving severe PH in heart transplant candidates by means of ventricular assist device (VAD) implantation and subsequent OHTX. In 11 heart transplantation candidates with severe PH unresponsive to pharmacological intervention we implanted VAD with the aim of achieving PH to values acceptable for OHTX. In all patients we observed significant drop in pulmonary pressures, PVR and TPG (p<0.001 for all) 3 months after VAD implantation to values sufficient to allow OHTX. Seven patients underwent transplantation (mean duration of support 216 days) while none of patients suffered right-side heart failure in postoperative period. Two patients died after transplantation and five patients are living in very good condition with a mean duration of 286 days after OHTX. In our opinion, severe PH is not a contraindication for orthotopic heart transplantation any more.
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční selhání $x chirurgie $x komplikace $x patofyziologie $7 D006333
- 650 _2
- $a transplantace srdce $x kontraindikace $7 D016027
- 650 _2
- $a podpůrné srdeční systémy $7 D006353
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a plicní hypertenze $x etiologie $x patofyziologie $x prevence a kontrola $7 D006976
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dorazilová, Zora $7 xx0075745 $u Department of Cardiology, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Netuka, Ivan, $d 1973- $7 xx0074183 $u Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Malý, Jan, $d 1943-2021 $7 nlk19990073523 $u Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Al-Hiti, Hikmet, $7 xx0073834 $u Department of Cardiology, Institute for Clinical and Experimental Medicine – IKEM, Prague $d 1970-
- 700 1_
- $a Melenovský, Vojtěch $7 xx0160847 $u Department of Cardiology, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Skalský, Ivo $7 xx0097370 $u Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Říha, Hynek. $7 xx0185812 $u Department of Anaesthesiology and Resuscitation, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Málek, Ivan, $d 1942- $7 nlk20030129885 $u Department of Cardiology, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Kautzner, Josef, $d 1957- $7 xx0037112 $u Department of Cardiology, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Pirk, Jan, $d 1948- $7 nlk19990073700 $u Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 773 0_
- $t Physiological research $x 0862-8408 $g Roč. 60, č. 5 (2011), s. 769-775 $w MED00003824
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 2 $z 0
- 990 __
- $a 20120229072848 $b ABA008
- 991 __
- $a 20141009172216 $b ABA008
- 999 __
- $a ok $b bmc $g 899523 $s 763296
- BAS __
- $a 3
- BMC __
- $a 2011 $b 60 $c 5 $d 769-775 $i 0862-8408 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- GRA __
- $a NS10497 $p MZ0
- LZP __
- $a 2012-12/ipme